nodes	percent_of_prediction	percent_of_DWPC	metapath
Mestranol—ESR1—urinary bladder cancer	0.933	1	CbGaD
Mestranol—CYP2C9—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00181	0.0317	CbGpPWpGaD
Mestranol—ESR1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.0018	0.0316	CbGpPWpGaD
Mestranol—CYP2C9—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00147	0.0257	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—urinary bladder cancer	0.0014	0.0246	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—XRCC1—urinary bladder cancer	0.00121	0.0212	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—HDAC4—urinary bladder cancer	0.00118	0.0208	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00111	0.0194	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—PHB—urinary bladder cancer	0.00109	0.0191	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.00104	0.0182	CbGpPWpGaD
Mestranol—ESR1—Nuclear signaling by ERBB4—RBX1—urinary bladder cancer	0.00101	0.0178	CbGpPWpGaD
Mestranol—Estriol—ESR2—urinary bladder cancer	0.000993	0.0969	CrCbGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000935	0.0164	CbGpPWpGaD
Mestranol—Quinestrol—ESR1—urinary bladder cancer	0.000926	0.0903	CrCbGaD
Mestranol—Estramustine—ESR2—urinary bladder cancer	0.000924	0.0901	CrCbGaD
Mestranol—ESR1—LKB1 signaling events—TSC1—urinary bladder cancer	0.000879	0.0154	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptors—ESR2—urinary bladder cancer	0.000872	0.0153	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—ESR2—urinary bladder cancer	0.00082	0.0144	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000813	0.0143	CbGpPWpGaD
Mestranol—Estropipate—ESR2—urinary bladder cancer	0.00076	0.0741	CrCbGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000754	0.0132	CbGpPWpGaD
Mestranol—ESR1—Nuclear signaling by ERBB4—S100B—urinary bladder cancer	0.000733	0.0129	CbGpPWpGaD
Mestranol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000702	0.0123	CbGpPWpGaD
Mestranol—CYP2C9—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000693	0.0122	CbGpPWpGaD
Mestranol—Desogestrel—ESR1—urinary bladder cancer	0.000693	0.0676	CrCbGaD
Mestranol—ESR1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.000689	0.0121	CbGpPWpGaD
Mestranol—ESR1—Nuclear signaling by ERBB4—NCOR1—urinary bladder cancer	0.000659	0.0116	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CCNE1—urinary bladder cancer	0.00064	0.0112	CbGpPWpGaD
Mestranol—Estriol—ESR1—urinary bladder cancer	0.000612	0.0597	CrCbGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—urinary bladder cancer	0.000574	0.0101	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000569	0.00999	CbGpPWpGaD
Mestranol—Estramustine—ESR1—urinary bladder cancer	0.000569	0.0555	CrCbGaD
Mestranol—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000567	0.00996	CbGpPWpGaD
Mestranol—Etonogestrel—ESR1—urinary bladder cancer	0.000561	0.0547	CrCbGaD
Mestranol—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000543	0.0529	CrCbGaD
Mestranol—ESR1—FOXM1 transcription factor network—CDK4—urinary bladder cancer	0.00049	0.0086	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptors—PPARG—urinary bladder cancer	0.000482	0.00847	CbGpPWpGaD
Mestranol—Conjugated Estrogens—ESR2—urinary bladder cancer	0.000474	0.0462	CrCbGaD
Mestranol—Estrone—ESR2—urinary bladder cancer	0.000473	0.0461	CrCbGaD
Mestranol—Estropipate—ESR1—urinary bladder cancer	0.000468	0.0456	CrCbGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—NCOR1—urinary bladder cancer	0.000443	0.00778	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000432	0.00759	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—urinary bladder cancer	0.000431	0.00756	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CREBBP—urinary bladder cancer	0.000428	0.00751	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—RB1—urinary bladder cancer	0.000426	0.00748	CbGpPWpGaD
Mestranol—ESR1—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.000412	0.00723	CbGpPWpGaD
Mestranol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—urinary bladder cancer	0.000405	0.00711	CbGpPWpGaD
Mestranol—Levonorgestrel—ESR1—urinary bladder cancer	0.000397	0.0387	CrCbGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000396	0.00695	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—PLAU—urinary bladder cancer	0.000395	0.00693	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—RHOA—urinary bladder cancer	0.000394	0.00692	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000392	0.00689	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.000387	0.0068	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000382	0.00671	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000381	0.00669	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CDKN2A—urinary bladder cancer	0.000375	0.00657	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—CDK4—urinary bladder cancer	0.000373	0.00655	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—TERT—urinary bladder cancer	0.000372	0.00654	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000367	0.00645	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.000367	0.00645	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.000367	0.00645	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000362	0.00636	CbGpPWpGaD
Mestranol—Danazol—ESR1—urinary bladder cancer	0.000361	0.0352	CrCbGaD
Mestranol—Estradiol—ESR2—urinary bladder cancer	0.000358	0.0349	CrCbGaD
Mestranol—ESR1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000345	0.00605	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—RBX1—urinary bladder cancer	0.000341	0.00598	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.000336	0.0059	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—ATM—urinary bladder cancer	0.000335	0.00587	CbGpPWpGaD
Mestranol—Ethinyl Estradiol—ESR1—urinary bladder cancer	0.000334	0.0326	CrCbGaD
Mestranol—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000331	0.00582	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000326	0.00572	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—RB1—urinary bladder cancer	0.000325	0.0057	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.000322	0.00565	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CCND1—urinary bladder cancer	0.000316	0.00555	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—urinary bladder cancer	0.000313	0.0055	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000302	0.00531	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000299	0.00525	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000298	0.00524	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000297	0.00522	CbGpPWpGaD
Mestranol—Conjugated Estrogens—ESR1—urinary bladder cancer	0.000292	0.0285	CrCbGaD
Mestranol—Estrone—ESR1—urinary bladder cancer	0.000291	0.0284	CrCbGaD
Mestranol—ESR1—FOXM1 transcription factor network—EP300—urinary bladder cancer	0.000291	0.00511	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00029	0.00509	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—SRC—urinary bladder cancer	0.000289	0.00507	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000285	0.005	CbGpPWpGaD
Mestranol—ESR1—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.000281	0.00493	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000271	0.00475	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000263	0.00462	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000261	0.00457	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—CXCL8—urinary bladder cancer	0.000259	0.00454	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000256	0.00449	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—MYC—urinary bladder cancer	0.000254	0.00445	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000253	0.00444	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—MYC—urinary bladder cancer	0.000249	0.00437	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000249	0.00437	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—S100B—urinary bladder cancer	0.000247	0.00433	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—RHOA—urinary bladder cancer	0.000243	0.00427	CbGpPWpGaD
Mestranol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000241	0.00423	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.000241	0.00423	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.00024	0.0042	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	0.000239	0.0042	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000236	0.00414	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000231	0.00405	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000226	0.00397	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000226	0.00396	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.000225	0.00395	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000222	0.0039	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	0.000222	0.0039	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	0.000221	0.00387	CbGpPWpGaD
Mestranol—Estradiol—ESR1—urinary bladder cancer	0.000221	0.0215	CrCbGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.00022	0.00386	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000218	0.00383	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000216	0.00379	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	0.000215	0.00378	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.00021	0.00369	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000208	0.00365	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	0.000205	0.00359	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000204	0.00358	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.000203	0.00357	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000203	0.00356	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000201	0.00353	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000199	0.00349	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000198	0.00348	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000194	0.0034	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00019	0.00334	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000187	0.00328	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000185	0.00325	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000181	0.00318	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000181	0.00318	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.00018	0.00315	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	0.000178	0.00313	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000177	0.0031	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000176	0.00309	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	0.000173	0.00303	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000172	0.00302	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	0.000169	0.00296	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000169	0.00296	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000166	0.00291	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000161	0.00282	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000156	0.00274	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000153	0.00269	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000153	0.00268	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000151	0.00264	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.00015	0.00263	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000146	0.00257	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000146	0.00256	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000139	0.00243	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	0.000128	0.00225	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000127	0.00223	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000126	0.00221	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	0.000125	0.0022	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000119	0.00209	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000116	0.00204	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000114	0.002	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.00011	0.00193	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	0.000109	0.00192	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	0.000109	0.00192	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000108	0.0019	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000107	0.00187	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000107	0.00187	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000105	0.00184	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000104	0.00183	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	9.94e-05	0.00174	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.8e-05	0.00172	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	9.42e-05	0.00165	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	9.19e-05	0.00161	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	9.12e-05	0.0016	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	9.11e-05	0.0016	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	9.09e-05	0.0016	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	8.92e-05	0.00157	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	8.87e-05	0.00156	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	8.67e-05	0.00152	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	8.43e-05	0.00148	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	8.43e-05	0.00148	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	8.38e-05	0.00147	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	7.68e-05	0.00135	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	7.56e-05	0.00133	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	7.49e-05	0.00131	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	7.39e-05	0.0013	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	7.12e-05	0.00125	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	7.04e-05	0.00124	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.98e-05	0.00123	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	6.63e-05	0.00116	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	6.58e-05	0.00116	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—SMC1A—urinary bladder cancer	6.57e-05	0.00115	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	6.44e-05	0.00113	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	6.32e-05	0.00111	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NAT1—urinary bladder cancer	6.28e-05	0.0011	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	6.28e-05	0.0011	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.21e-05	0.00109	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.18e-05	0.00108	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	5.75e-05	0.00101	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—ESR2—urinary bladder cancer	5.73e-05	0.00101	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.17e-05	0.000908	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	4.88e-05	0.000857	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	4.76e-05	0.000836	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NCOR1—urinary bladder cancer	4.42e-05	0.000776	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	4.41e-05	0.000775	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—ERCC2—urinary bladder cancer	4.16e-05	0.00073	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	4.15e-05	0.000728	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	3.95e-05	0.000693	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.82e-05	0.00067	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TYMP—urinary bladder cancer	3.81e-05	0.000668	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	3.75e-05	0.000659	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.66e-05	0.000642	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.44e-05	0.000604	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—S100B—urinary bladder cancer	3.2e-05	0.000561	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PPARG—urinary bladder cancer	3.17e-05	0.000556	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—CREBBP—urinary bladder cancer	3.04e-05	0.000534	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.97e-05	0.000521	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	2.88e-05	0.000505	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.75e-05	0.000483	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.75e-05	0.000483	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.74e-05	0.00048	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.67e-05	0.000468	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.63e-05	0.000461	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TERT—urinary bladder cancer	2.53e-05	0.000445	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	2.33e-05	0.000408	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.22e-05	0.000389	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.15e-05	0.000378	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	1.98e-05	0.000347	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	1.96e-05	0.000343	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.88e-05	0.000329	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.85e-05	0.000325	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—MYC—urinary bladder cancer	1.81e-05	0.000317	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.79e-05	0.000314	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.79e-05	0.000314	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.72e-05	0.000302	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.7e-05	0.000298	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.7e-05	0.000298	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.66e-05	0.000291	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.63e-05	0.000286	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.6e-05	0.000281	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.57e-05	0.000276	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.5e-05	0.000264	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.5e-05	0.000264	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.46e-05	0.000257	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.42e-05	0.00025	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.42e-05	0.000249	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.41e-05	0.000248	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.35e-05	0.000237	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SRC—urinary bladder cancer	1.31e-05	0.00023	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.22e-05	0.000214	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MYC—urinary bladder cancer	1.17e-05	0.000206	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.17e-05	0.000205	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	1.15e-05	0.000202	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	1.09e-05	0.000191	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TP53—urinary bladder cancer	9.65e-06	0.000169	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	9.58e-06	0.000168	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	9.23e-06	0.000162	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.36e-06	0.000147	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—EP300—urinary bladder cancer	7.97e-06	0.00014	CbGpPWpGaD
